Market Overview

Family Dollar, Dollar Tree 'Clearly' Have 'A Lot Of Work Ahead'


Family Dollar Stores, Inc. (NYSE: FDO) reported earnings Wednesday morning. Additionally, Dollar Tree, Inc. (NASDAQ: DLTR) also provided an update on the merger.

Analysts at FBR & Co. said in reaction that Dollar Tree "clearly has a lot of work in front of it," noting that the number of stores that the FTC would like to see divested is 340, up from 300 prior. FBR opined that the reason that the FTC was requiring more stores to be sold is in expectation that some of those stores would fail under new management. Notably, FBR said that it does not expect Dollar General Corp. (NYSE: DG) to be a major buyer of these 340 stores.

However, beyond the divestiture, FBR believes that Family Dollar's challenges are "far more structural" than the Street is willing to acknowledge. While Dollar Tree will eventually be able to "fix" Family Dollar, in FBR's view, the integration will be "vastly more troubled and time consuming" than many believe.

FBR has a Market Perform rating on Family Dollar.

Shares of Family Dollar recently traded at $79.68, down 0.36 percent.

Latest Ratings for FDO

Apr 2015MaintainsHold
Jan 2015MaintainsEqual-Weight
Jan 2015DowngradesBuyHold

View More Analyst Ratings for FDO
View the Latest Analyst Ratings

Posted-In: dollar general Dollar Tree family dollar FBR & Co.Analyst Color Analyst Ratings


Related Articles (DLTR + DG)

View Comments and Join the Discussion!

Latest Ratings

ELMDDougherty & Co.Initiates Coverage On12.0
MRNSCantor FitzgeraldAssumes7.0
MNRLCapital One FinancialInitiates Coverage On23.0
SONVertical GroupUpgrades
UNPMorgan StanleyMaintains136.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

USDA Wheat Data

Biogen Investors: Active Ingredient In Patient Death Is Not Changing BofA's Forecast